President Donald Trump has been pressuring pharmaceutical companies to lower U.S. drug costs, and it may be starting to work – at least on AstraZeneca. AstraZeneca has proposed price cuts to certain drugs in the U.S., its CEO Pascal Soriot told reporters on Tuesday, after the company’s second-quarter revenue and earnings topped estimates. “We have […]
